Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04912479 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Can Connected Devices Increase the Success Rate of Benzodiazepine Withdrawals in the Elderly?

Study acronym: BENZO-E-STOP
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 25, 2024 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Notable Primary and study completion dates: Feb 1, 2024 to Feb 1, 2026 Site contact updatedv5 Show 1 more changeShow less
    • Site contact updated
  3. Notable Primary and study completion dates: Feb 1, 2023 to Feb 1, 2024v4
  4. Notable Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 1, 2021 to Oct 14, 2021 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Oct 1, 2021 to Oct 14, 2021
    • Site details revised
  5. Notable Start date: Jul 1, 2021 to Oct 1, 2021 Eligibility criteria shortened, about 2 wordsv2 Show 1 more changeShow less
    • Eligibility criteria shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective randomized open study, which aims to evaluate the benefit of a connected watch to help people aged 65 years and older to withdraw from BZD over a six-month period, compared with classical withdrawal (e.g without connected watch). The study will include 100 patients, 50 in the control group and 50 in the intervention group. Participants will be identified during a 12-month period through either external geriatric consultations or during a brief hospitalisation.
Trial Details
NCT Number NCT04912479
Lead Sponsor University Hospital, Toulouse
Conditions Benzodiazepine Withdrawal
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov